Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer

Por Bašová, Petra, Pešta, Michal, Sochor, Marek, Stopka, Tomáš
Publicado no Int J Mol Sci (2017)

Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

Por Sochor, Marek, Basova, Petra, Pesta, Michal, Dusilkova, Nina, Bartos, Jiri, Burda, Pavel, Pospisil, Vit, Stopka, Tomas
Publicado em 2014

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas

Por Dusílková, Nina, Bašová, Petra, Polívka, Jindřich, Kodet, Ondřej, Kulvait, Vojtěch, Pešta, Michal, Trněný, Marek, Stopka, Tomáš
Publicado no Int J Mol Sci (2017)

Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders

Por Polgarova, Kamila, Vargova, Karina, Kulvait, Vojtech, Dusilkova, Nina, Minarik, Lubomir, Zemanova, Zuzana, Pesta, Michal, Jonasova, Anna, Stopka, Tomas
Publicado no Oncotarget (2017)